The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.

 
Web www.patentalert.com

< Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract

< Sulfated fucoglucuronomannan

> Isopropanolate of azithromycin and method of manufacturing

> Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
~ 00283